Reprogrammed NK immune cells target cancer and autoimmune disorders

T1Covered by 1 source · first reported by MIT News (research) / Quanta / The Conversation at 13 Oct, 09:00 UTC

A new approach can program these cells inside the body and shows promise against diseases caused by dysfunctional T cells, including lymphoma and autoimmune hepatitis.